Lassa fever case management capacity in ECOWAS Region: Progress, gaps, and policy recommendations
Open Access
- 1 July 2020
- journal article
- Published by African Field Epidemiology Network in Journal of Interventional Epidemiology and Public Health
- Vol. 9 (Suppl 12)
Abstract
Introduction: Lassa fever remains a significant public health concern in the ECOWAS region. Prompt diagnosis and effective case management are critical for controlling outbreaks and reducing associated mortality and severe complications. This study assessed the case management capacity for Lassa fever across ECOWAS member states, focusing on early detection, diagnostics, treatment infrastructure, and infection prevention and control (IPC) measures. Methods: A cross-sectional, mixed-methods study was conducted using structured questionnaires, key informant interviews, and document reviews in 10 ECOWAS member states. The evaluation encompassed diagnostic capacities, treatment availability, IPC measures, and workforce readiness. Thematic and comparative analyses were employed to synthesize the findings. Results: Considerable differences were observed across participating Member States. Nigeria, Guinea, and Liberia demonstrated relative strengths in diagnostics and treatment infrastructure. In contrast, countries such as Gambia, Ghana, and Côte d’Ivoire exhibited serious shortcomings, revealing significant deficiencies in healthcare worker training and access to antiviral therapies. The implementation of standardised case management protocols was inconsistent. Additionally, data sharing challenges and inadequate coordination across borders were highlighted as significant issues. Conclusion: While progress has been made, substantial gaps remain in Lassa fever case management across ECOWAS. Strategic investments in health systems strengthening, legal frameworks development for data sharing, and capacity building are critical to improving regional preparedness and reducing the risk of future outbreaks.Keywords
This publication has 21 references indexed in Scilit:
- Lassa fever — the road aheadNature Reviews Microbiology, 2022
- Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysisInternational Journal of Infectious Diseases, 2019
- Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018New England Journal of Medicine, 2018
- The challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected settingInternational Journal of Infectious Diseases, 2018
- Laboratory Diagnosis of Lassa FeverJournal of Clinical Microbiology, 2017
- Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to EbolaThe Lancet, 2015
- What is a resilient health system? Lessons from EbolaThe Lancet, 2015
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa FeverClinical Infectious Diseases, 2010
- Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus IsolationJournal of Clinical Microbiology, 2000
- Lassa FeverNew England Journal of Medicine, 1986